Oue Lippo Healthcare Ltd
SGX:5WA
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.025
0.031
|
Price Target |
|
We'll email you a reminder when the closing price reaches SGD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Oue Lippo Healthcare Ltd
Free Cash Flow
Oue Lippo Healthcare Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
O
|
Oue Lippo Healthcare Ltd
SGX:5WA
|
Free Cash Flow
S$70.1m
|
CAGR 3-Years
193%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
17%
|
|
Raffles Medical Group Ltd
SGX:BSL
|
Free Cash Flow
S$72.2m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
||
I
|
ISEC Healthcare Ltd
SGX:40T
|
Free Cash Flow
S$10.6m
|
CAGR 3-Years
7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
A
|
Asia Vets Holdings Ltd
SGX:5RE
|
Free Cash Flow
-S$699.8k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Thomson Medical Group Ltd
SGX:A50
|
Free Cash Flow
S$56.5m
|
CAGR 3-Years
33%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
Oue Lippo Healthcare Ltd
Glance View
OUE Lippo Healthcare Ltd. is as an investment holding company, which engages in the provision of healthcare services and facilities. The firm owns, operates and invests in healthcare businesses Asian markets. The Company’s segments include Healthcare operations, Healthcare assets, Properties under development and Investments. The Healthcare Operations segment includes the operation of hospitals and trading of pharmaceutical supplies and drugs and has operations in China and Myanmar. The Properties under development segment includes development of medical facilities, healthcare-related assets and integrated mixed-used projects and has development properties in China and Malaysia. The Healthcare assets segment includes rental of investment properties and assets owned by the Company and has assets in Japan and China. The Investments segment has investments in real estate investment trust (REIT) and REIT manager. OUELH also holds a 50% equity interest in China Merchants Lippo Hospital Management (Shenzhen) Limited (CM Lippo).
See Also
What is Oue Lippo Healthcare Ltd's Free Cash Flow?
Free Cash Flow
70.1m
SGD
Based on the financial report for Jun 30, 2024, Oue Lippo Healthcare Ltd's Free Cash Flow amounts to 70.1m SGD.
What is Oue Lippo Healthcare Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
17%
Over the last year, the Free Cash Flow growth was 61%. The average annual Free Cash Flow growth rates for Oue Lippo Healthcare Ltd have been 193% over the past three years , and 17% over the past ten years .